These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 25361040
1. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in a university teaching hospital. Osawa K, Shigemura K, Shimizu R, Kato A, Kusuki M, Jikimoto T, Nakamura T, Yoshida H, Arakawa S, Fujisawa M, Shirakawa T. Microb Drug Resist; 2015 Apr; 21(2):130-9. PubMed ID: 25361040 [Abstract] [Full Text] [Related]
2. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J. J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692 [Abstract] [Full Text] [Related]
4. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Peirano G, Costello M, Pitout JD. Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869 [Abstract] [Full Text] [Related]
10. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases. Giedraitienė A, Vitkauskienė A, Pavilonis A, Patamsytė V, Genel N, Decre D, Arlet G. Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748 [Abstract] [Full Text] [Related]
11. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN). J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690 [Abstract] [Full Text] [Related]
12. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? Ewers C, Bethe A, Stamm I, Grobbel M, Kopp PA, Guerra B, Stubbe M, Doi Y, Zong Z, Kola A, Schaufler K, Semmler T, Fruth A, Wieler LH, Guenther S. J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338 [Abstract] [Full Text] [Related]
18. Prevalence of CTX-M-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli B2-O25-ST131 H30R Among Residents in Nonacute Care Facilities in Japan. Kawamura K, Hayashi K, Matsuo N, Kitaoka K, Kimura K, Wachino JI, Kondo T, Iinuma Y, Murakami N, Fujimoto S, Arakawa Y. Microb Drug Resist; 2018 Dec; 24(10):1513-1520. PubMed ID: 29791251 [Abstract] [Full Text] [Related]
19. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates. Graham SE, Zhang L, Ali I, Cho YK, Ismail MD, Carlson HA, Foxman B. Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781 [Abstract] [Full Text] [Related]
20. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany. Pietsch M, Eller C, Wendt C, Holfelder M, Falgenhauer L, Fruth A, Grössl T, Leistner R, Valenza G, Werner G, Pfeifer Y, RESET Study Group. Vet Microbiol; 2017 Feb; 200():130-137. PubMed ID: 26654217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]